AKE 0.00% $9.83 allkem limited

Merger: Yes or No, page-629

  1. 1,628 Posts.
    lightbulb Created with Sketch. 640
    How can it be independent if AKE paid for it?
    It is not an Expert Report either. Its quality is mediocre at best.
    The report blatantly misses many critical aspects and analyses related to this merger. Many things are buried within the 630 pages of Scheme booklet or not mentioned at all.
    KROLL's EXPERT statement: KROLL supports the merger as long as AKE holder are not worse off!

    That statement in itself is a slap into every AKE holder's face.
    Many on here have provided facts and evidence that AKE shareholders will be worse off.

    I posted this before. It is telling every AKE holder what they really need to know about this reverse takeover.
    AKE holder are going to be 100% worse off if we merge with Livent.
    All the synergies savings and accreditations are not going to make up for the loss in investment returns that AKE sharaholders will incur thanks to an US-listing.
    return comparison.png
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.